Mergers & Acquisitions · Oct 14, 2026

Silo Pharma acquires software and IP from Larry King for 150,000 shares

SILOSilo Pharma, Inc.

On October 13, 2026, Silo Pharma entered into an asset purchase agreement to acquire certain software and related intellectual property from Larry King. In consideration, the company issued 150,000 shares of common stock subject to a twelve-month lock-up period. The transaction was conducted under Section 4(a)(2) of the Securities Act. Silo Pharma operates in the pharmaceutical industry.